Acp-103-057-005
ClinicalTrials.gov NCT03325556
Research payments
$102,770
Through program year 2022, $102,770 in research payments was reported against Acp-103-057-005, across 12 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT03325556
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $102,770 | 12 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Ledoux Memphis, TN Named on 1 payment
- Sanjay Yathiraj Bradenton, FL Named on 1 payment
- Ramon Gil Port Charlotte, FL Named on 1 payment
- Angel Carrasco Miami, FL Named on 1 payment
- Deborah Green Laroche Boston, MA Named on 1 payment
- Diego Rielo Miami Lakes, FL Named on 1 payment
- Andrew Ridder Sioux Falls, SD Named on 1 payment
- Zehra Farzal West Bloomfield, MI Named on 1 payment
- Hernan Pabon Miami, FL Named on 1 payment
- Guillermo Blanco North Miami Beach, FL Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.